Galderma has agreed to acquire ZO Skin Health from investors including Blackstone and the Obagi family for an enterprise value of $1.5 billion. The transaction adds approximately $330 million in annual sales and a network of more than 16,500 professional accounts, although near-term integration spending is expected to weigh on margins.
KKR’s agreement to acquire Integer Holdings joins the multibillion-dollar privatisation of Hologic and American Industrial Partners’ purchase of Avanos Medical. The transactions differ substantially, but together they show why specialised medtech manufacturers, platforms and established healthcare franchises remain attractive to private capital even when near-term growth is uneven.
Find out how Hologic’s patent victory against Siemens Healthineers could reshape breast cancer detection technology and medtech competition.
Angelini gains U.S. rare disease scale. Catalyst gets certainty, but Firdapse concentration keeps the real test ahead.